Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kaladhar B Reddy

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Cancer Cell International|May 12, 2015
MicroRNA (miRNA) in cancerKaladhar B Reddy
Genes|November 25, 2020
Stem Cells: Current Status and Therapeutic ImplicationsKaladhar B Reddy
International Journal of Oncology|March 3, 2007
Inhibition of the MAP kinase activity suppresses estrogen-induced breast tumor growth both in vitro and in vivoKaladhar B Reddy, Selina Glaros
Molecular Cancer Research : MCR|October 1, 2003
Distinct mechanisms mediate the initial and sustained phases of cell migration in epidermal growth factor receptor-overexpressing cellsJoseph S Kruger, Kaladhar B Reddy
Journal of Cellular Biochemistry|July 29, 2010
Protein kinase Cδ and caspase-3 modulate TRAIL-induced apoptosis in breast tumor cellsShuping Yin, Seema Sethi, Kaladhar B Reddy
Cancer Metastasis Reviews|July 30, 2003
Role of MAP kinase in tumor progression and invasionKaladhar B Reddy, Sanaa M Nabha, Natasha Atanaskova
Genes & Cancer|January 25, 2021
Novel strategies to target chemoresistant triple-negative breast cancerJaganathan Venkatesh, Arun K Rishi, Kaladhar B Reddy
Oncology Reports|January 17, 2015
Anti-estrogen‑resistant breast cancer cells are sensitive to cisplatin plus TRAIL treatmentShuping Yin, Arun K Rishi, Kaladhar B Reddy
The Journal of Biological Chemistry|April 19, 2002
Mechanism of 17-beta-estradiol-induced Erk1/2 activation in breast cancer cells. A role for HER2 AND PKC-deltaVenkateshwar G Keshamouni, Raymond R Mattingly, Kaladhar B Reddy
Cells|May 13, 2026
A Novel Mechanism of STAT3 Activation by Oncogenic SignalingMagesh Muthu, Jaganathan Venkatesh, Kaladhar B Reddy, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Cancer Cell International|May 12, 2015
MicroRNA (miRNA) in cancerKaladhar B Reddy
Genes|November 25, 2020
Stem Cells: Current Status and Therapeutic ImplicationsKaladhar B Reddy
International Journal of Oncology|March 3, 2007
Inhibition of the MAP kinase activity suppresses estrogen-induced breast tumor growth both in vitro and in vivoKaladhar B Reddy, Selina Glaros
Molecular Cancer Research : MCR|October 1, 2003
Distinct mechanisms mediate the initial and sustained phases of cell migration in epidermal growth factor receptor-overexpressing cellsJoseph S Kruger, Kaladhar B Reddy
Journal of Cellular Biochemistry|July 29, 2010
Protein kinase Cδ and caspase-3 modulate TRAIL-induced apoptosis in breast tumor cellsShuping Yin, Seema Sethi, Kaladhar B Reddy
Cancer Metastasis Reviews|July 30, 2003
Role of MAP kinase in tumor progression and invasionKaladhar B Reddy, Sanaa M Nabha, Natasha Atanaskova
Genes & Cancer|January 25, 2021
Novel strategies to target chemoresistant triple-negative breast cancerJaganathan Venkatesh, Arun K Rishi, Kaladhar B Reddy
Oncology Reports|January 17, 2015
Anti-estrogen‑resistant breast cancer cells are sensitive to cisplatin plus TRAIL treatmentShuping Yin, Arun K Rishi, Kaladhar B Reddy
The Journal of Biological Chemistry|April 19, 2002
Mechanism of 17-beta-estradiol-induced Erk1/2 activation in breast cancer cells. A role for HER2 AND PKC-deltaVenkateshwar G Keshamouni, Raymond R Mattingly, Kaladhar B Reddy
Cells|May 13, 2026
A Novel Mechanism of STAT3 Activation by Oncogenic SignalingMagesh Muthu, Jaganathan Venkatesh, Kaladhar B Reddy, et al.
Pageof 2